260 research outputs found

    Divergence-free approach for obtaining decompositions of quantum-optical processes

    Full text link
    Operator-sum representations of quantum channels can be obtained by applying the channel to one subsystem of a maximally entangled state and deploying the channel-state isomorphism. However, for continuous-variable systems, such schemes contain natural divergences since the maximally entangled state is ill-defined. We introduce a method that avoids such divergences by utilizing finitely entangled (squeezed) states and then taking the limit of arbitrary large squeezing. Using this method we derive an operator-sum representation for all single-mode bosonic Gaussian channels where a unique feature is that both quantum-limited and noisy channels are treated on an equal footing. This technique facilitates a proof that the rank-one Kraus decomposition for Gaussian channels at its respective entanglement-breaking thresholds, obtained in the overcomplete coherent state basis, is unique. The methods could have applications to simulation of continuous-variable channels.Comment: 18 pages (8 + appendices), 4 figs. V2: close to published version, dropped Sec.VI of v1 to be expanded elsewher

    Nanoindentation studies on waveguides inscribed in chalcogenide glasses using ultrafast laser

    Get PDF
    Optical straight waveguides are inscribed in GeGaS and GeGaSSb glasses using a high repetition-rate sub-picosecond laser. The mechanical properties of the glasses in the inscribed regions, which have undergone photo induced changes, have been evaluated by using the nanoindentation technique. Results show that the hardness and elastic modulus of the photo-modified glasses are significantly lower as compared to the other locations in the waveguide, which tend to be similar to those of the unexposed areas. The observed mechanical effects are found to correlate well with the optical properties of the waveguides. Further, based on the results, the minimum threshold values of hardness and elastic modulus for the particular propagation mode of the waveguide (single or multi), has been established

    3-Methyl-5-(3-phenoxy­phen­yl)cyclo­hex-2-enone

    Get PDF
    In the title mol­ecule, C19H18O2, the cyclo­hexene ring adopts an envelope conformation, with all substituents equatorial. The dihedral angle between the benzene and phenyl rings is 83.75 (16)°. No classical hydrogen bonds are found in the crystal structure

    3-Methyl-5-(4-methyl­phen­yl)cyclo­hex-2-enone

    Get PDF
    In the title mol­ecule, C14H16O, the cyclo­hexene ring adopts an envelope conformation, with all substituents equatorial. Mol­ecules are linked by C—H⋯O hydrogen bonds. A C—H⋯π inter­action involving the benzene ring is also found in the crystal structure. The H atoms of both methyl groups are disordered equally over two positions

    A high gain pifa at 2.45 GHz and 5.8 GHz using wireless power transfer techniques for pacemaker application

    Get PDF
    The design of a high gain Planar Inverted F Antenna (PIFA) with two different frequencies for medical pacemaker is presented. Two PIFA designs have been optimized to be operated at ISM band of 2.45 GHz and 5.8 GHz respectively, under tolerable reflection coefficient of less than -10dB. Both of the proposed antennas are developed from copper plate with a simple structure of rectangular patch. All design and simulation has been carried out using Computer Simulation Technology (CST) Microwave Studio Suite. The simulated and measured results of the fabricated antenna on reflection coefficient, bandwidth radiation pattern, and gain are presented to validate the usefulness of the presented design. The 2D Anechoic Chamber and Agilent Technologies Network Analyzer have been used for the measurement. Both 2.45 GHz and 5.8 GHz antennas have successfully manage to achieve high gain of 6dB and 8.2dB respectively with a directional beam pattern. The presented ISM PIFAs could be potential for point-to-point communication using wireless power transfer technique for medical pacemaker application

    5-(4-Chloro­phen­yl)-1-methyl-3-oxocyclo­hexa­necarbonitrile

    Get PDF
    In the title mol­ecule, C14H14ClNO, the cyclo­hexane ring adopts a chair conformation. The cyano group and the methyl group have axial and equatorial orientations, respectively. The benzene ring has an equatorial orientation. A C—H⋯π inter­action involving the benzene ring is found in the crystal structure

    A Patternless Piezoelectric Energy Harvester for Ultra Low Frequency Applications

    Get PDF
    This paper presents a pattern less piezoelectric harvester for ultra low power energy applications. Usually patterned cantilevers are used as vibration energy harvester which results additional fabrication process. Hence, to reduce the process, a four layer cantilever configuration is used to design the harvester with Aluminum, Silicon and Zinc Oxide. The device dimension is settled to 12×10×≈0.5009 mm3 with ≈300 nm deposition thickness for each layer. The modeling and fabrication processes are demonstrated in detail. The induced voltage by the cantilever is obtained through the analytical and practical measurements. From the measurements, it is found that, the maximum induced voltage is 91.2 mV from practical measurement with voltage density of 1.517 mV/mm3. It is evident from the results that, this pattern less model can be useful for next generation vibration energy harvester with simpler technology

    Is home-based HIV testing universally acceptable? Findings from a case-control study nested within the HPTN 071 (PopART) trial.

    Get PDF
    OBJECTIVE: The HPTN 071 (PopART) trial is examining the impact of a package including universal testing and treatment on community-level HIV incidence in Zambia and South Africa. We conducted a nested case-control study to examine factors associated with acceptance of home-based HIV testing and counselling (HB-HTC) delivered by community HIV-care providers (CHiPs) in PopART intervention communities. METHODS: Of 295 447 individuals who were offered testing, random samples of individuals who declined HB-HTC (cases) and accepted HB-HTC (controls), stratified by gender and community, were selected. Odds ratios comparing cases and controls were estimated using multivariable logistic regression. RESULTS: Data from 642 participants (313 cases, 329 controls) were analysed. There were no differences between cases and controls by demographic or behavioural characteristics including age, marital or socio-economic position. Participants who felt they could be open with CHiPs (AOR: 0.46, 95% CI: 0.30-0.71, P < 0.001); self-reported as not previously tested (AOR: 0.64; 95% CI: 0.43-0.95, P = 0.03); considered HTC at home to be convenient (AOR: 0.38, 95% CI: 0.27-0.54, P = 0.001); knowing others who had accepted HB-HTC from the CHiPs (AOR: 0.49, 95% CI: 0.31-0.77, P = 0.002); or were motivated to get treatment without delay (AOR: 0.60, 95% CI: 0.43-0.85, P = 0.004) were less likely to decline the offer of HB-HCT. Those who self-reported high-risk sexual behaviour were also less likely to decline HB-HCT (AOR: 0.61, 95% CI: 0.39-0.93, P = 0.02). Having stigmatising attitudes about HB-HTC was not an important barrier to HB-HCT uptake. Men who reported fear of HIV were more likely to decline HB-HCT (AOR: 2.68, 95% CI: 1.33-5.38, P = 0.005). CONCLUSION: Acceptance of HB-HTC was associated with lack of previous HIV testing, positive attitudes about HIV services/treatment and perception of high sexual risk. Uptake of HB-HCT among those offered it was similar across a range of demographic and behavioural subgroups suggesting it was 'universally' acceptable

    Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal

    Get PDF
    Background: The Universal HIV Test and Treat (UTT) strategy represents a challenge for science, but is also a challenge for individuals and societies. Are repeated offers of provider-initiated HIV testing and immediate antiretroviral therapy (ART) socially-acceptable and can these become normalized over time? Can UTT be implemented without potentially adding to individual and community stigma, or threatening individual rights? What are the social, cultural and economic implications of UTT for households and communities? And can UTT be implemented within capacity constraints and other threats to the overall provision of HIV services? The answers to these research questions will be critical for routine implementation of UTT strategies. Methods/design: A social science research programme is nested within the ANRS 12249 Treatment-as-Prevention (TasP) cluster-randomised trial in rural South Africa. The programme aims to inform understanding of the (i) social, economic and environmental factors affecting uptake of services at each step of the continuum of HIV prevention, treatment and care and (ii) the causal impacts of the TasP intervention package on social and economic factors at the individual, household, community and health system level. We describe a multidisciplinary, multi-level, mixed-method research protocol that includes individual, household, community and clinic surveys, and combines quantitative and qualitative methods. Discussion: The UTT strategy is changing the overall approach to HIV prevention, treatment and care, and substantial social consequences may be anticipated, such as changes in social representations of HIV transmission, prevention, HIV testing and ART use, as well as changes in individual perceptions and behaviours in terms of uptake and frequency of HIV testing and ART initiation at high CD4. Triangulation of social science studies within the ANRS 12249 TasP trial will provide comprehensive insights into the acceptability and feasibility of the TasP intervention package at individual, community, patient and health system level, to complement the trial's clinical and epidemiological outcomes. It will also increase understanding of the causal impacts of UTT on social and economic outcomes, which will be critical for the long-term sustainability and routine UTT implementation. Trial registration: Clinicaltrials.gov: NCT01509508; South African Trial Register: DOH-27-0512-3974
    corecore